MDxHealth (MDXH) Receivables (2020 - 2026)

MDxHealth has reported Receivables for 8 years, with the latest figure at $14.3 million in Q1 2026.

• Quarterly Receivables fell 8.24% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (down 8.24% YoY) and the FY2025 annual result came in at $14.7 million, up 2465.56% from the prior year.
• Receivables eased to $14.3 million in Q1 2026 per MDXH's latest filing, from $14.7 million in the prior quarter.
• Over five years, Receivables peaked at $18.2 million in Q3 2025 and troughed at $572000.0 in Q4 2024.
• A 5-year average of $9.4 million and a median of $9.3 million in 2022 frame the typical range for Receivables.
• The widest YoY moves for Receivables: up 2465.56% in 2025, down 75.9% in 2025.
• Over 5 years, Receivables stood at $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then plunged by 52.33% to $572000.0 in 2024, then jumped by 2465.56% to $14.7 million in 2025, then slipped by 2.82% to $14.3 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $14.3 million, $14.7 million, and $18.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.